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Mass spectrometryThe vaccinia virus entry–fusion complex (EFC) consists of 10 to 12 proteins that are embedded in the viral
membrane and individually required for fusion with the cell and entry of the core into the cytoplasm. The
architecture of the EFC is unknown except for information regarding two pair-wise interactions: A28 with H2
and A16 with G9. Here we used a technique to destabilize the EFC by repressing the expression of individual
components and identiﬁed a third pair-wise interaction: G3 with L5. These two proteins remained associated
under several different EFC destabilization conditions and in each case were immunopuriﬁed together as
demonstrated by Western blotting. Further evidence for the speciﬁc interaction of G3 and L5 was obtained by
mass spectrometry. This interaction also occurred when G3 and L5 were expressed in uninfected cells,
indicating that no other viral proteins were required. Thus, the present study extends our knowledge of the
protein interactions important for EFC assembly and stability.lth, 33 North Drive, Bethesda,
Inc.Published by Elsevier Inc.Introduction
Poxviruses, of which vaccinia virus (VACV) is the prototype, are
distinguished by their large size and cytoplasmic site of transcription,
DNA replication and virion assembly (Moss, 2007). The major
infectious form of VACV, the mature virion (MV), has a nucleoprotein
core comprised of a 195-kbp dsDNA genome and 50 or more proteins
(Chung et al., 2006; Resch et al., 2007; Yoder et al., 2006). Surrounding
the core is a lipid membrane with about 25 associated proteins.
Several of the latter have overlapping or redundant roles in mediating
the binding of the MV to the host cell. A27, H3, and D8 associate with
glycosaminoglycans on the cell surface and A26 binds to laminin
(Chiu et al., 2007; Chung et al., 1998; Hsiao et al., 1999; Lin et al.,
2000). The L1 protein has also been suggested to have a role in
binding, although no receptor has been identiﬁed (Foo et al., 2009).
A large number of proteins have been implicated in the membrane
fusion step, creating a pore for entry of the core into the cytoplasm
(Moss, 2006). Using genetic and biochemicalmethods, 12 such proteins
were identiﬁed: A16 (Ojeda et al., 2006a, 2006b), A21 (Townsley et al.,
2005), A28 (Senkevich et al., 2004), F9 (Brown et al., 2006), G3
(Izmailyan et al., 2006), G9 (Ojeda et al., 2006a, 2006b), H2 (Senkevich
andMoss, 2005), I2 (Nichols et al., 2008), J5 (Senkevich et al., 2005), L1
(Bisht et al., 2008), L5 (Townsley et al., 2005) and O3 (Satheshkumar
andMoss, 2009). Each one, except J5, has been shown to be individually
required for entry and except for I2, the proteins have been shown toassociate as a complex.Nineof theseproteins (A16,A21,A28,G3,G9,H2,
J5, L5, and O3) have been designated as integral components of the
entry–fusion complex (EFC) because absence of any one results in the
destabilization of the complex. L1 and F9 are also associated with the
complex but are not required for EFC assembly or stability, suggesting
that they may be associated peripherally.
Very little is known about the architecture of the EFC and even less is
known about the speciﬁc roles of EFC proteins in virus entry. Previous
studies indicated that theproteinsof theEFC trafﬁc independently to the
viral membrane yet the complex seems to be held together by multiple
interactions since the absence of single components destabilizes the EFC
in the presence of Triton X-100 (Senkevich et al., 2005). The latter
observation has provided a way to identify pair-wise protein interac-
tions that persist under destabilization conditions. With this approach,
interactions between H2 and A28 (Nelson et al., 2008) and between G9
and A16 (Wagenaar et al., 2008) were discovered and conﬁrmed by
transfection studies in uninfected cells. The present study extends our
knowledge of the protein interactions important for EFC assembly and
stability. Using the EFC destabilization approach in infected cells and
coexpression in uninfected cells, we obtained evidence for direct
association of the G3 and L5 proteins.
Results and discussion
G3 and L5 remained associated when the entry–fusion complex was
destabilized
We implemented the EFC destabilization approach by attempting to
determinewhich if any proteins remained associatedwith G3 under such
279C.L. Wolfe, B. Moss / Virology 412 (2011) 278–283conditions. Human 293TT cells were infected with several different
inducible recombinant viruses in the presence or absence of isopro-
pylthiogalactoside (IPTG) and transfected with a plasmid encoding a V5
epitope-taggedG3proteinor anemptyvector. After 24 hat 37 °C, the cells
were harvested and lysed with 1% Triton X-100. Following a brief
centrifugation, the post-nuclear supernatants were analyzed by Western
blotting either directly (Input) or after immunoafﬁnity puriﬁcation (IP)
with anti-V5 agarose. Analysis of the Input conﬁrmed that the inducible
genes of the VACV recombinants vA16i, vA21i, vJ5i, and vG9i were
severely repressed in the absence of IPTG, whereas the other EFC proteins
analyzed were expressed (Fig. 1 and data not shown). In addition,
representative EFC proteins expressed in the presence of IPTG copuriﬁed
with theV5-taggedG3protein, indicating that the latterwas incorporated
into the stable complex (Fig. 1).We compared the relative amounts of the
EFC proteins that copuriﬁed with G3V5 in the presence and absence of
IPTG. In each condition, the intensity of the L5 band was similar whereas
other EFC proteins only associated strongly with G3V5 in the presence of
IPTG. The association of L5with G3was speciﬁc since L5was not detected
after IP when the vector plasmid was transfected (Fig. 1).
To conﬁrm the interaction between G3 and L5, we made
recombinant VACVs with an inducible A21 gene that also expressed
either C-terminal strep-tagged G3 or strep-8xhis-tagged L5 (Figs. 2A
and 3A). Use of these recombinant viruses had advantages over the
above infection/transfection protocol: (i) untagged copies of G3 and
L5 were not present to compete with the tagged version; (ii) scale up
was simpler as transfection was not needed. BS-C-1 cells were
infected with vA21i as a control or vA21iG3strep with or without
IPTG. After 24 h, the cells were harvested, lysed with Triton X-100,
clariﬁed and allowed to bind to streptactin beads. The bound proteins
were eluted with biotin and analyzed by Western blotting. In the
presence of IPTG, A16, A21, A28 and L5 copuriﬁed with G3strep
indicating the presence of a stable complex, whereas only L5
copuriﬁed with G3 strep in the absence of IPTG (Fig. 2B). Similarly,
cells were infected with vA21i as a control or vA21iL5strep-8xhis with
or without IPTG. A16, A21, A28 and G3 copuriﬁed with L5strep-8xhis
in the presence of IPTG but only G3 copuriﬁed with L5strep-8xhis in
the absence of IPTG (Fig. 3B). These data provided further evidence for
an interaction between G3 and L5.Fig. 1. IP of L5 with G3V5 under EFC destabilization conditions. Human 293TT cells were infe
(B) A21i, (C) G9i, or (D) vﬂagJ5i and transfected with vector alone (V) or vector encoding G3
before (Input) or after (V5 IP) IP with anti-V5 beads. Antibodies to A16, A21, A28, G3, G9, LDetection of the interaction between G3 and L5 by mass spectrometry
The above data provided evidence for an interaction between G3
and L5, though not necessarily direct as we could not screen for all of
the EFC proteins because antibodies to some were not available or not
useful because of low afﬁnity or poor speciﬁcity. Mass spectrometry
was used as an alternative to Western blotting in order to conﬁrm the
interaction of G3 and L5 and determine whether any other proteins
were associated with them under EFC destabilization conditions. BS-
C-1 cells were infected with vA21i as a control or vA21iG3strep or
vA21iL5strep-8xhis with or without IPTG as in the preceding section.
However, after elution from streptactin beads, the proteins were
separated by sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PAGE) and stained with Coomassie blue. Visible protein
bands from the vA21iG3strep (+IPTG) and vA21iL5strep-8xhis
(+IPTG) lanes were excised for identiﬁcation by mass spectrometry.
Corresponding regions from lanes loaded with proteins from cells
infected with vA21i in the presence of IPTG and from cells infected
with vA21iG3strep and vA21iL5strep-8xhis in the absence of IPTG
were also excised for protein identiﬁcation. When IPTG was present
and A21 was expressed in cells infected with vA21iG3strep, mass
spectrometry analysis indicated that A16, G9, F9, H2, A21, A28, L5 and
G3 had bound and were eluted together from streptactin-beads. Only
G9, L5 and G3 were detected, however, when A21 expression was
repressed by omission of IPTG in vA21iG3strep infected cells (Fig. 4A,
Table 1). When cells were infected with vA21iL5strep-8xhis under
conditions in which A21 was expressed, EFC proteins A16, G9, F9, H2,
A21, A28, and G3 copuriﬁed with L5 strep on streptactin-beads. Only
L5 and G3 were detected when A21 was not expressed (Fig. 4B,
Table 1). These data conﬁrmed the interaction of G3 and L5 and also
suggested an interaction with G9. However, G9 is not required for the
interaction of G3 and L5 as shown in Fig. 1. No other EFC proteins were
detected in association with G3 or L5 under destabilizing conditions.
However, we cannot exclude an interaction with I2 and O3, which
have not been detected by mass spectroscopy either in this
experiment or in others probably because of their small size and
hydrophobicity, or with J5, which was not detected in the +IPTG
control.cted with the following viruses in the presence (+) and absence (−) of IPTG: (A) A16i,
V5. The Triton X-100 soluble fraction of infected cells was analyzed byWestern blotting
5, ﬂag and V5 were used for probing the blot as indicated.
Fig. 2. IP of L5 with G3strep under EFC destabilization conditions. (A) Diagram of G3strep recombinant DNA inserted into vA21i. Arrows over the ORFs indicate the direction of
transcription. The construct includes the G3L ORF encoding a C-terminal Strep3 tag under the control of the native G3L promoter, a copy of the DsRed ORF under the control of the
VACV P11 late promoter, and VACV ﬂanking sequences to allow homologous recombination. (B) Human 293TT cells were infected with vA21i or vA21iG3strep in the presence (+)
and absence (−) of IPTG. Triton X-100 soluble extracts were analyzed byWestern blotting before (Input) and after strep IP with streptactin beads. Antibodies to A21, A28, G3 and L5
were detected by ﬂuorescence. Antibody to A16 was detected by chemiluminescence.
Fig. 3. IP of G3 with L5strep-8xhis under EFC destabilization conditions. (A) Diagram of L5strep-8xhis recombinant DNA inserted into vA21i. Arrows over ORFs indicate the direction
of transcription. The construct includes the L5R ORF encoding a C-terminal strep tag followed by 8xhis tag under the control of the native L5R promoter, a copy of the DsRed ORF
under the control of the VACV P11 late promoter and VACV ﬂanking sequences to allow homologous recombination. Note: Because of overlap between the downstream ORF of L5
and the upstream ORF of J1 this region (L5/J1) was duplicated in the construct to allow addition of the strep-8xhis tag to the carboxy terminus of L5. Silent mutations were also
incorporated in L5/J1 region to prevent instability of the genome due to repeat DNA sequences. (B) Human 293TT cells were infected with vA21i or vA21iL5strep-8xhis (abbreviated
vA21iL5strep) in the presence (+) and absence (−) of IPTG. Triton X-100 soluble extracts were analyzed byWestern blotting before (Input) and after strep IP with streptactin beads.
Antibodies to A21, A28, and L5 were detected by ﬂuorescence. Antibodies to A16 and G3 were detected by chemiluminescence.
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Fig. 4. Identiﬁcation by mass spectrometry of EFC proteins associated with G3strep and L5strep-8xhis in the absence of A21. (A) BS-C-1 cells were infected with vA21i or
vA21iG3strep with (+) or without (−) IPTG. Infected cells were harvested after 24 h and lysed in 1% triton X-100. After a brief centrifugation the postnuclear supernatant was
incubated with streptactin-beads for 3.5 h. Bound protein was eluted with biotin and separated by SDS-PAGE. Protein bands stained with Coomassie blue are shown with the
positions of mass marker proteins in kDa on the left. The numbers on the right are the names of proteins that copuriﬁed with G3strep as determined by mass spectrometry. Those in
parentheses copuriﬁed in the absence of A21 expression. Note thatmultiple proteins comigrated under these conditions and some bands are faint. (B) BS-C-1 cells were infected with
vA21i or vA21iL5strep-8xhis (abbreviated vA21iL5strep) with (+) or without (−) IPTG and analyzed as in panel A.
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To provide further evidence for a direct interaction between G3
and L5, we expressed the proteins in uninfected human 293TT cells.
The G3 and L5 open reading frames (ORFs) were codon optimized for
expression in human cells and tagged with strep and 3×ﬂag epitopes,
respectively. In addition, since the EFC proteins are not glycosylated in
the viral membrane, a potential N-glycosylation site in L5 was
removed by an S117A replacement. The modiﬁed G3strep and
L5ﬂag ORFs were cloned into separate plasmid vectors under the
control of the cytomegalovirus early promoter. Human 293TT cells
were transfected with G3strep and L5ﬂag plasmids separately or
together. After 48 h, the cells were lysed with Triton X-100 detergent,
and the post nuclear supernatants were incubated with either anti-
ﬂag agarose or streptactin-beads. The proteins in the postnuclear
supernatant and eluate fractions were resolved by SDS-PAGE and
analyzed by Western blotting. The G3 antibody was able to detect
G3strep eluted from anti-ﬂag agarose only when co-expressed with
L5ﬂag (Fig. 5). Reciprocally, the L5 antibody was only able to detect
L5ﬂag eluted from streptactin-beads when it was co-expressed with
G3strep (Fig. 5). We concluded that the interaction between G3 and
L5 was stable and did not require other viral proteins.Table 1











G3 – 5 4 6 5
L5 – 6 3 6 5
A28 – 3 – 2 –
A21 – 2 – 1 –
H2 – 8 – 4 –
F9 – 6 – 2 –
G9 – 12 4 4 –
A16 – 13 – 11 –
a The number of peptides for each EFC protein identiﬁed bymass spectrometry is listed.
b vA21iL5strep-8xhis is abbreviated as vA21iL5strep.Conclusions
Previous studies had shown pair-wise interactions between the
A28 and H2 and between the A16 and G9 components of the EFC. The
purpose of the present study was to determine the interaction partner
(s) of the G3 protein. We found by IP and Western blotting that G3
and L5 interact under conditions in which the EFC is destabilized by
repression of A16, A21, A28, G9 or J5. This result was conﬁrmed in
several ways. First, wemade recombinant viruses in which expression
of A21was repressed and either G3 or L5was epitope-tagged and then
demonstrated the interaction by IP followed by Western blotting and
mass spectrometry. Mass spectrometry also identiﬁed G9 in associ-
ation with G3, suggesting an additional interaction that needs to be
veriﬁed by further experiments including the construction of
additional recombinant viruses. However, G3 and L5 were still
associated when G9 was repressed indicating that the latter does
not mediate G3 and L5 interactions. Further evidence for the
interaction of G3 and L5 was obtained by their expression in
uninfected cells, indicating that no other viral proteins are required.Fig. 5. Interaction between G3 and L5 in uninfected cells. (Left) Cells were cotransfected
with the plasmid encoding L5ﬂag and either the empty vector or the plasmid
expressing G3strep. The postnuclear supernatant (Input) and afﬁnity bound proteins
were analyzed by SDS-PAGE and Western blotting with antibody to G3 or L5. (Right)
Cells were cotransfected with the plasmid encoding G3strep and either the empty
vector or the plasmid expressing L5ﬂag. The postnuclear supernatant (Input) and
afﬁnity bound proteins were analyzed by SDS-PAGE and Western blotting with
antibody to G3 or L5.
282 C.L. Wolfe, B. Moss / Virology 412 (2011) 278–283At present we are exploring additional methods of determining the
architecture of the EFC.
Materials and methods
Cells and viruses
BS-C-1 cells were grown inminimum essential mediumwith Earl's
balanced salts (Quality Biological, Gaithersburg, MD) supplemented
with 2 mM L-Gln and 10% fetal bovine serum (FBS). Human 293TT
cells were grown in Dulbecco's minimum essential medium (DMEM:
Quality Biological) supplemented with 10% FBS, 2 mM L-Gln. The
Western Reserve (WR) strain of vaccinia virus (ATCC VR-1354;
accession number AY243312) was used in the construction of
plasmids expressing EFC proteins and recombinant viruses. The
general procedures for preparing and titrating virus stocks were
described previously (Earl et al., 1998a; Earl and Moss, 1998).
Expression plasmids
For expression of G3V5 protein in VACV-infected cells, the G3L
promotor and ORF were ampliﬁed by PCR (Accuprime PFX, Invitro-
gen) using the genomic DNA of VACV as a template. The forward
primer for G3L ampliﬁcation hybridized at 64 bp upstream of the G3L
ORF. The coding sequence for the V5 tag was included at the 5′ end of
the reverse primer. The structures were veriﬁed by DNA sequencing.
For expression of the VACV proteins G3 and L5 in uninfected cells,
their DNA sequences were optimized (Geneart, Regensburg, Germany)
to alter codon usage and G-C content to improve RNA processing and
translation. A potential glycosylation site in L5was removed by a S115A
mutation. TheseDNA sequenceswere ampliﬁed by PCRwith oneprimer
also coding for the appropriate epitope tag and then inserted into
pcDNA3.3 vector (Invitrogen) under the control of the early cytomeg-
alovirus promotor. In that way the following plasmids were con-
structed: L5ﬂag (3×ﬂag epitope appended to C terminal end); G3strep
(StrepIII tag: WSHPQFEKGGGSGGGSGGGSWSHPQFEK) appended to C
terminal end (Schmidt and Skerra, 2007).
Recombinant VACV construction
Recombinant viruses vA21iG3strep and vA21iL5strep-8xhis were
modiﬁed from vA21i (Townsley et al., 2005) by the insertion of DNA
encoding Discosoma sp. DsRed ﬂuorescent protein and appending the
strepIII tag sequence and StrepIII-8his tag sequence to the 3′ ends of
the G3L and L5R ORFs, respectively. (Notation: “v” refers to virus; “i”
indicates inducible gene; and strep indicates strepIII tag at the 3′ end
of the ORF.) Overlapping PCR (Accuprime Pfx; Invitrogen) was used to
assemble the DNA constructs for subsequent virus recombination.
Following PCR, the construct was cloned into pCR-Blunt II-TOPO
(Invitrogen) and veriﬁed by DNA sequencing. vA21i infected BS-C-1
cells were transfected with linearized G3strep or L5strep-8xhis
recombinant DNA using Lipofectamine 2000 (Invitrogen). IPTG
(100 μm) was added to the medium to induce expression of the
A21i gene. Recombinant virus was identiﬁed by red ﬂuorescence and
clonally puriﬁed during several rounds of plaque isolation as
described previously (Earl et al., 1998b).
The DNA arrangement from the 5′ to the 3′ end of the linearized
G3strep recombinant DNA was as follows: 1) begins 500 bp from the
5′ end of the G1L ORF continuing 45 bp upstream of the G1L ORF, 2)
red ﬂuorescent protein (DsRed) ORF expressed from p11, a VACV late
promoter, and 3) G3L ORF with strepIII tag appended to the C
terminus and continuing 200 bp upstream of the G3L ORF.
The DNA sequence from the 5′ to the 3′ end of the linearized
L5strep-8xhis construct was as follows: 1) begins 233 bp upstream of
the L5R ORF with the strepIII tag followed by the 8xhis tag appended
to 3′ end of the L5R ORF, 2) red ﬂuorescent protein (DsRed) ORFexpressed from p11, and 3) duplication of the L5/J1 overlapping
region beginning 91 bp upstream of the 3′ end of L5R ORF and
extending through the J1 ORF to 48 bp past the 3′ end. Duplication of
L5/J1 overlapping region allowed normal expression of J1 as it
includes the J1 promoter. Silent mutations were introduced into the 3′
end of L5 ORF (L5/J1 overlap region) to avoid direct repeats, which are
unstable in the VACV genome.
Afﬁnity puriﬁcation
Two roller bottles with BS-C-1 cells were infected for 2 h with 5
PFU per cell of vA21i or vA21iG3strep in the presence of 100 μM IPTG
or 10 PFU of vA21iG3strep in the absence of IPTG. After removal of the
virus inoculum, 150 ml of EMEM (2.5% FBS, 2 mM Gln) was added to
each roller bottle. After 24 h, the cells were harvested and lysed for 1 h
at 4 °C with rotation in 2 ml of 0.1 M sodium phosphate buffer (PBS)
(pH 8.0), 0.2 M NaCl, 1% Triton X, 100 μg/ml avidin, and protease
inhibitors: phenylmethanesulfonyl ﬂuoride (Sigma-Aldrich, St. Louis),
N-ethylmaleimide (Sigma-Aldrich, St. Louis), and EDTA free complete
protease inhibitor cocktail tablet (Roche, Indianapolis). The debris
was removed by centrifugation for 10 min at 10,600×g. The lysate
was incubated with 50 μl streptactin beads (IBA, Gottingen, Germany)
on a rotator for 4 h. The supernatant was removed after 30 s
centrifugation at 6000×g. The beads were washed four times by
centrifuging after incubating in lysis buffer for 3 min. The ﬁnal wash
was with lysis buffer without Triton X-100. Bound protein was eluted
with a 3-min incubation with (IBA, Gottingen, Germany) biotin
elution buffer (50 μl) followed by brief centrifugation. Elution was
repeated with 100 μl of biotin elution buffer. The eluates were
combined, concentrated and separated by SDS-PAGE. The gel was
stained with Coomassie blue, protein bands were cut from the gel,
digested with trypsin and analyzed by mass spectrometry by the
National Institute of Allergy and Infectious Diseases core facility.
Immunoafﬁnity puriﬁcation
For transfection of uninfected cells, one T150 ﬂask of 293TT cells in
DMEM, 10% FBS, 2 mM Gln was transfected with 30 μg of plasmid
preincubated with Lipofectamine 2000 (Invitrogen). After 24 h, fresh
DMEM, 10% FBS, 2 mM Gln was added and the cells were harvested
after an additional 24 h.
For combined infection and transfection experiments, one T150
ﬂask plated with 293TT cells was infected with 3 to 5 PFU per cell in
DMEM with 2.5% FBS, 2 mM Gln for 1 h at 37 C. The growth medium
was removed and cells were washed twice with DMEM. Twenty-ﬁve
milliliter of DMEM with 2.5% FBS, 2 mM Gln was added and the cells
were then transfected with 30 μg of plasmid/Lipofectamine 2000.
After 24 h, the cells were harvested.
Human 293TT cells in each T150 ﬂask were lysed in 1 ml of buffer
containing 0.1 M sodium phosphate, 0.15 M NaCl, 1% Triton X-100
supplemented with protease inhibitors at pH 7.4 when incubated
with V5- or ﬂag-antibody resins or at pH 8.0 for lysates incubated with
streptactin beads. After 1 h at 4 °C, the debris was removed by
centrifugation for 10 min at 10,600×g. An aliquot was saved for
analysis of the postnuclear supernatant/cell extract. The remainder
was rotated overnight with 20–30 μl of packed beads of streptactin
(IBA), ﬂag- or V5-antibody conjugated agarose (Bethyl, Montgomery,
TX). In the morning the beads were spun down by centrifugation at
3000×g for 3 min and thenwashed 5×with lysis buffer supplemented
with phenylmethanesulfonyl ﬂuoride and N-ethylmaleimide. Each
wash was followed by a 2-min incubation on ice and then a 4 s spin at
6000×g. NuPage 2× LDS protein sample buffer (Invitrogen) was
added and the bound proteins were eluted by heating at 95 °C for
4 min followed by 5 min centrifugation at 16,000×g. The reducting
agent, 0.1 M dithiothreitol ﬁnal concentration, was added prior to
SDS-PAGE.
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Whole-cell lysates or puriﬁed proteins were resolved by SDS-PAGE
on 4 to 12% Novex NuPAGE acrylamide gels with 2-(N-morpholino)
ethanesulfonic acid–SDS running buffer and transferred to nitrocel-
lulose membranes using mini iBlot gel transfer stacks (Invitrogen).
The membrane was blocked with 5% nonfat milk in PBS containing
0.05% Tween 20 and then incubated with a primary antibody
overnight at 4 °C and washed with PBS containing Tween 20 followed
by PBS without detergent. For chemiluminescence detection, the
appropriate secondary antibody conjugated with horseradish perox-
idase (Pierce, Rockford, IL) was added and the blot was washed and
developed using Dura or Femto chemiluminescent substrate (Pierce).
For ﬂuorescent detection, donkey anti-mouse IRDye 680/800 and
donkey anti-rabbit IRDye 680/800 were used and developed using a
LI-COR Odyssey infrared imager (LI-COR Biosciences, Lincoln, NE). To
reprobe the blots with additional antibodies, the nitrocellulose
membrane was stripped at 55 °C for 20 min using Restore buffer
(Pierce) or Newblot Nitro stripping buffer (LI-COR).
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